Shares of Plus Therapeutics Inc. (PSTV) are surging over 55% in pre-market today, after the company announced a definitive agreement to license multiple rare cancer drug product candidates from private Texas-based radiotherapeutic company NanoTx Therapeutics Inc.
from RTT - Before the Bell https://ift.tt/2WV2kO2
via IFTTT
No comments:
Post a Comment